http://mobile.bloomberg.com/news/2013-03-13/novartis-and-merck-drugs-don-t-stop-sars-related-virus-in-study.html
Posted but Rob LS
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment